DOCS — Dr Martens Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsSpeculativeMid CapSuper Stock

Annual income statement for Dr Martens, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	672	773	908	1,000	877
Cost of Revenue
Gross Profit	402	471	579	618	575
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	530	661	679	824	755
Operating Profit	143	113	229	176	122
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	101	70.9	214	159	93
Provision for Income Taxes
Net Income After Taxes	74.8	35.7	181	129	69.2
Net Income Before Extraordinary Items
Net Income	74.8	35.7	181	129	69.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	74.8	35.7	181	129	69.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.084	0.077	0.181	0.132	0.07
Dividends per Share